StockGlow

Novartis AG (0QLR.IL)

Makes medicines for heart disease, cancer, eye problems, and immune disorders.

129.08-0.00%Healthcare
Compare 0QLR.IL with
StockGlow Score
92
Bullish
BearishBullish
1 year ago+37.1%

The outlook

Novartis (0QLR.IL) is trading near its 52-week highs, well above both its 50- and 200-day moving averages, reflecting sustained upward momentum. The stock carries a trailing P/E of 40.2, which is elevated relative to historical norms. Analyst sentiment leans constructive based on available data.

What’s behind the score

Price trendAbove its 50- & 200-day averages
52-week range94% of the way from its 52-week low to high
Market cap
$295.96B
52-wk high
131.50
52-wk low
91.66
50-day avg
122.01
200-day avg
116.02
Trailing P/E
40.2

Similar stocks

0QOK.ILRoche Holding AG$323.90+0.00%0O59.ILSanofi$79.99+0.39%0QR4.ILNestlé S.A.$82.60+1.56%0QIU.ILNovo Nordisk A/S$333.50+0.27%0O87.ILTelefonaktiebolaget LM Ericsson (publ)$95.98+1.29%

The StockGlow Score is a snapshot of current, observable market data (analyst ratings, price trend, 52-week range) — not a prediction, forecast, or recommendation. Informational only, not investment advice. Data from public sources and may be delayed. How this works·Privacy